LCM
GBT

Landscape Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Landscape Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-42,200
Closed -$1.78M – 1079
2015
Q3 		$1.78M Buy
+42,200
New +$1.99M 0.24% 67

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Landscape Capital Management's GBT Position: Q4 2015 in Review

Landscape Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2015, closing a stake of 42,200 shares — an estimated $1.78M sold.

Landscape Capital Management first reported a position in GBT in Q3 2015 and held it in 1 quarter. The position peaked at $1.78M in Q3 2015. 68 funds tracked by Wall St. Rank hold GBT as of Q4 2015.

  • Landscape Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Landscape Capital Management sold 42,200 Global Blood Therapeutics, Inc. shares in Q4 2015, an estimated $1.78M.
  • Landscape Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 1 quarter.
  • Landscape Capital Management's Global Blood Therapeutics, Inc. position peaked at $1.78M in Q3 2015.
  • 68 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2015.

Based on Landscape Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.